Ömer Faruk Turan

601 total citations
36 papers, 229 citations indexed

About

Ömer Faruk Turan is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Neurology. According to data from OpenAlex, Ömer Faruk Turan has authored 36 papers receiving a total of 229 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pathology and Forensic Medicine, 12 papers in Molecular Biology and 10 papers in Neurology. Recurrent topics in Ömer Faruk Turan's work include Multiple Sclerosis Research Studies (19 papers), Peripheral Neuropathies and Disorders (6 papers) and Sphingolipid Metabolism and Signaling (4 papers). Ömer Faruk Turan is often cited by papers focused on Multiple Sclerosis Research Studies (19 papers), Peripheral Neuropathies and Disorders (6 papers) and Sphingolipid Metabolism and Signaling (4 papers). Ömer Faruk Turan collaborates with scholars based in Türkiye, Montenegro and Saudi Arabia. Ömer Faruk Turan's co-authors include Kenan Aydoğan, Selçuk Onart, Özlem Taşkapılıoğlu, Şükran Tunalı, Bahattin Hakyemez, Mehmet Zarifoğlu, Ender Kurt, Özkan Kanat, Türkkan Evrensel and Güzin Gönüllü and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Journal of Radiology and Clinical Rheumatology.

In The Last Decade

Ömer Faruk Turan

27 papers receiving 220 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ömer Faruk Turan Türkiye 9 84 42 41 36 30 36 229
Josiah Chai Singapore 7 33 0.4× 24 0.6× 72 1.8× 14 0.4× 15 0.5× 18 308
Eva Schmidt Germany 8 76 0.9× 5 0.1× 109 2.7× 40 1.1× 24 0.8× 14 299
Nofrat Schwartz United States 12 43 0.5× 6 0.1× 70 1.7× 73 2.0× 3 0.1× 23 338
Everardo Hernández-Quíntela Mexico 14 21 0.3× 30 0.7× 46 1.1× 23 0.6× 62 2.1× 65 693
Qiu-Jie Zhao China 5 21 0.3× 21 0.5× 148 3.6× 54 1.5× 7 0.2× 5 371
E Martin France 9 12 0.1× 13 0.3× 44 1.1× 86 2.4× 14 0.5× 23 329
Anjana Nigam India 5 23 0.3× 15 0.4× 31 0.8× 33 0.9× 36 1.2× 10 259
Jinhee Kim South Korea 10 10 0.1× 7 0.2× 86 2.1× 26 0.7× 21 0.7× 24 305
Vered Pinsk Israel 11 11 0.1× 36 0.9× 73 1.8× 9 0.3× 4 0.1× 27 382
Vivian Rismondo United States 9 15 0.2× 45 1.1× 72 1.8× 3 0.1× 54 1.8× 12 321

Countries citing papers authored by Ömer Faruk Turan

Since Specialization
Citations

This map shows the geographic impact of Ömer Faruk Turan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ömer Faruk Turan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ömer Faruk Turan more than expected).

Fields of papers citing papers by Ömer Faruk Turan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ömer Faruk Turan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ömer Faruk Turan. The network helps show where Ömer Faruk Turan may publish in the future.

Co-authorship network of co-authors of Ömer Faruk Turan

This figure shows the co-authorship network connecting the top 25 collaborators of Ömer Faruk Turan. A scholar is included among the top collaborators of Ömer Faruk Turan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ömer Faruk Turan. Ömer Faruk Turan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Koç, Emine Rabia, et al.. (2025). Characteristics of pain in patients with NMOSD and MOGAD: impact on mental health, sleep and quality of life. Neurological Sciences. 46(9). 4555–4567.
2.
Koç, Emine Rabia, et al.. (2025). Real-world experience of ocrelizumab in patients with multiple sclerosis: A single-center study. Neurology Asia. 30(1). 251–259.
3.
Koç, Emine Rabia, et al.. (2024). Fingolimod real life experience in non-naive multiple sclerosis patients. The European Research Journal. 10(5). 430–438.
4.
Koç, Emine Rabia, et al.. (2024). Effects of disease-modifying therapies on remyelination in multiple sclerosis; evaluation via visual evoked potential test. Multiple Sclerosis and Related Disorders. 91. 105850–105850. 3 indexed citations
5.
Koç, Emine Rabia, et al.. (2024). Coexistence of epilepsy or seizure and multiple sclerosis; a single center experience. Multiple Sclerosis and Related Disorders. 92. 105948–105948. 1 indexed citations
6.
Terzi, Murat, Bahattin Avcı, Ömer Faruk Turan, et al.. (2024). The role of oligoclonal band count and IgG index in treatment response and disease activity in multiple sclerosis. Multiple Sclerosis and Related Disorders. 83. 105391–105391. 3 indexed citations
7.
Taşkapılıoğlu, Özlem, Gülşah Çeçener, Ünal Egelí, et al.. (2023). Investigation of miR-146a Expression Profiles in Fecal Samples of Patients With Multiple Sclerosis for Early Diagnosis and Treatment. SHILAP Revista de lepidopterología. 40(2). 81–87. 3 indexed citations
8.
Ünal, Aysun, Hüsnü Efendi, Mesrure Köseoğlu, et al.. (2023). Use of follow-on fingolimod for multiple sclerosis: Analysis of effectiveness and patient reported outcomes in a real-world clinical setting. Multiple Sclerosis and Related Disorders. 77. 104880–104880. 1 indexed citations
9.
Boz, Cavit, Serkan Özakbaş, Murat Terzi, et al.. (2023). The comparative effectiveness of fingolimod, natalizumab, and ocrelizumab in relapsing-remitting multiple sclerosis. Neurological Sciences. 44(6). 2121–2129. 8 indexed citations
10.
Turan, Ömer Faruk, Mesrure Köseoğlu, & Emine Rabia Koç. (2022). Varicella zoster virus infection due to Pfizer-BioNTech mRNA COVID-19 vaccine and sinovac vaccine in two relapsing-remitting multiple sclerosis patients during fingolimod therapy. Bursa Uludag University - AVESIS. 2. 100078–100078.
11.
Taşkapılıoğlu, Özlem, et al.. (2018). The relationship between psychopathology, psychosocial adjustment, social support and quality of life in multiple sclerosis. The European Research Journal. 5(1). 20–28. 4 indexed citations
12.
Özakbaş, Serkan, Recai Türkoğlu, Yusuf Tamam, et al.. (2018). Prevalence of and risk factors for cognitive impairment in patients with relapsing-remitting multiple sclerosis: Multi-center, controlled trial. Multiple Sclerosis and Related Disorders. 22. 70–76. 28 indexed citations
13.
Kürtüncü, Murat, Uğur Uygunoğlu, Hüsnü Efendi, et al.. (2017). Differences Between General Neurologists and Multiple Sclerosis Specialists in the Management of Multiple Sclerosis Patients: A National Survey. Nöro Psikiyatri Arşivi. 56(4). 269–272. 4 indexed citations
14.
Taşkapılıoğlu, Özlem, et al.. (2016). Psychopathology, Psychosocial Factors and Quality of Life in Patients with Myasthenia Gravis. 33(3). 482–493. 3 indexed citations
15.
Sığırlı, Deniz, İlker Ercan, Senem Turan Özdemir, et al.. (2012). Shape Analysis of the Corpus Callosum and Cerebellum in Female MS Patients with Different Clinical Phenotypes. The Anatomical Record. 295(7). 1202–1211. 14 indexed citations
16.
Taşkapılıoğlu, Özlem, et al.. (2012). Relapsing-Remitting Multipl Skleroz Hastalarında Glatiramer Asetat Deneyimi. SHILAP Revista de lepidopterología. 18(1). 17–20.
17.
Aydoğan, Kenan, et al.. (2005). Audiological abnormalities in patients with vitiligo.. Clinical and Experimental Dermatology. 31(1). 110–113. 39 indexed citations
18.
Apaydın, Fazıl, et al.. (2004). Waardenburg-Syndrom. HNO. 52(6). 533–7. 4 indexed citations
19.
Kanat, Özkan, Türkkan Evrensel, İbrahim Baran, et al.. (2003). Protective Effect of Amifostine Against Toxicity of Paclitaxel and Carboplatin in Non-small Cell Lung Cancer: A Single Center Randomized Study. Medical Oncology. 20(3). 237–246. 36 indexed citations
20.
Turan, Ömer Faruk, et al.. (1995). Results of vaccinated infants born to HBsAg-positive mothers with different hepatitis B vaccines and doses.. PubMed. 37(2). 93–102. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Josiah Chai Breakdown of academic impact, for papers by Eva Schmidt Breakdown of academic impact, for papers by Nofrat Schwartz Breakdown of academic impact, for papers by Everardo Hernández-Quíntela Breakdown of academic impact, for papers by Qiu-Jie Zhao Breakdown of academic impact, for papers by E Martin Breakdown of academic impact, for papers by Anjana Nigam Breakdown of academic impact, for papers by Jinhee Kim Breakdown of academic impact, for papers by Vered Pinsk Breakdown of academic impact, for papers by Vivian Rismondo
Rankless by CCL
2026